› Bridging the gap between imaging and therapy - Jeroen van de Kamer, Nederlands Kanker Instituut
09:00-09:30 (30min)
› Image quality assessment on MRI for Radiotherapy Treatment Planning purpose - Ivan Gicquiau, Laboratoire Traitement du Signal et de lÍmage
09:30-10:00 (30min)
› MRI uniformity correction in Radiotherapy Treatment Planning - Louis Marage, Laboratoire Traitement du Signal et de lÍmage
10:00-10:30 (30min)
› MRI-only treatment planning - Christina Boydev, Le Centre Clinique de la Porte de Saint-Cloud
11:00-11:30 (30min)
› MRI Protocol Optimization for Radiotherapy Treatment Planning in Head and Neck Cancer - Axel Largent, Laboratoire Traitement du Signal et de lÍmage
11:30-12:00 (30min)
› MRI-based radiation therapy planning of prostate cancer using an atlas approach - Nick Reynaert, Center Oscar Lambret - Christina Boydev, Centre Oscar Lambret, Lille - Antoine Wagner, Centre Oscar Lambret, Lille
12:00-12:30 (30min)
› Multimodality imaging for holmium source distributions in the context of micro-brachytherapy -
14:00-14:25 (25min)
› Definition of a reference organ for lesion thresholding on 68Ga-DOTATATE PET/CT - Gwennaëlle Marin, Department of Electronics and Information Systems - Ghent University, Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles
14:25-14:50 (25min)
› Modelling of clinical dosimetry for targeted radionuclide therapy - Frederic CHATRIE, Centre de Recherche en Cancérologie de Toulouse
14:50-15:15 (25min)
› Quality assurance of activity administration in Selective Internal Radiation Therapy (SIRT) - Hugo Levillain, Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles
15:15-15:40 (25min)
› Diffusion weighted MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer: Preliminary results - Alexandre Escande, CRIStAL laboratory, UMR CNRS 9189,, Academic Department of Radiation Oncology, Oscar Lambret Comprehensive Cancer Center,
16:10-16:35 (25min)
› An innovative normalization method for MRI texture analysis to characterize tumor heterogeneity in glioblastoma - Anne-Sophie Dirand, Université Paris Sud, Université Paris-Saclay, F-94270, Le Kremlin-Bicêtre, Unité de radiothérapie moléculaire - Sylvain Reuzé, INSERM, U1030, F-94805, Villejuif, Gustave Roussy, Université Paris-Saclay, Department of Medical Physics, F-94270, Villejuif, Gustave Roussy, Université Paris-Saclay, Department of Radiotherapy, F-94805, Villejuif, Université Paris Sud, Université Paris-Saclay, F-94270, Le Kremlin-Bicêtre
16:35-17:00 (25min)
› Texture analysis on pre-brachytherapy MRI for predicting relapse in locally advanced cervical cancer - Anthony Alexis, Université Paris Sud, Université Paris-Saclay, F-94270, Le Kremlin-Bicêtre, INSERM, U1030, F-94805, Villejuif, Gustave Roussy, Université Paris-Saclay, Department of Medical Physics, F-94270, Villejuif - Sylvain Reuzé, Gustave Roussy, Université Paris-Saclay, Department of Radiotherapy, F-94805, Villejuif, Université Paris Sud, Université Paris-Saclay, F-94270, Le Kremlin-Bicêtre, INSERM, U1030, F-94805, Villejuif, Gustave Roussy, Université Paris-Saclay, Department of Medical Physics, F-94270, Villejuif
17:00-17:25 (25min)
› Absorbed dose estimation in patients treated with 177Lu-DOTATATE for peptide receptor radionuclide therapy - Erick Mora-Ramirez, University of Costa Rica, CICANUM, Physics School, San Pedro, San Jose, INSERM, UMR 1037, Toulouse III Paul Sabatier University, Toulouse, Cancer Research Centre of Toulouse
09:00-09:30 (30min)
› Towards a quality assurance for dosimetry in fractionated molecular radiotherapy (MRT) - Gwennaëlle Marin, Department of Electronics and Information Systems - Ghent University, Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles
09:30-10:00 (30min)
› Defining the therapeutic window of liver radioembolization (RE) based on predictive MAA-based dosimetry and assessment of liver function reserve using hepatobiliary scintigraphy (HBS) - Hugo Levillain, Department of Nuclear Medicine, Jules Bordet Institute, Université Libre de Bruxelles
10:00-10:30 (30min)
› Monte Carlo, robust planning or adaptive? - Edmond Sterpin, Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), Université Catholique de Louvain, Brussels, Belgium, Laboratory of Experimental Radiotherapy, Katholieke Universiteit Leuven, Leuven, Belgium
11:00-11:30 (30min)
› Monte-Carlo model of an EPID for a AQ/In-Vivo dosimetry project - Jeremy Leste, Centre de Recherche en Cancérologie de Toulouse
11:30-12:00 (30min)
› Monte Carlo calculation of absorbed doses due to imaging sessions delivered to patients during Tomotherapy Image-Guided RadioTherapy courses -
12:00-12:30 (30min)
› Computation of the RT dose of the day from mapping CBCT information to the planning CT using an optimized elastic registration method - Clément Chevillard, R&D Medical Physics, Radiotherapy Department
13:30-14:00 (30min)
› Automatic dose painting workflow: from tumor segmentation to optimization - Ana María Barragan Montero, Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), Université Catholique de Louvain, Brussels, Belgium
14:00-14:30 (30min)
› Integration of motion perturbations in a comprehensive robustness evaluator based on a fast Monte Carlo dose engine for PBS proton therapy - Kevin Souris, Université catholique de Louvain / Institut de Recherche Expérimentale et Clinique
14:30-15:00 (30min)
› Automated and robust dose restoration in IMPT: reaching dose stability under anatomical changes. - Kinga Bernatowicz, Université Catholique de Louvain, MIRO, Bruxelles, Belgique, MIRO Lab, IREC, Bruxelles
15:00-15:30 (30min)
› MRI standardisation - Trevor Esward, Simon Duane National Physics Laboratory
09:30-10:00 (30min)
› Measurements of lipid content by MRI: applications to liver and bone marrow - Hervé Saint-Jalmes, Centre Eugène Marquis, Laboratoire Traitement du Signal et de l'Image
10:00-10:30 (30min)
› QUANTITATIVE T1 MAPPING BY VARIABLE FLIP ANGLES (VFA) - Francois DUBUS, Centre Oscar Lambret, Lille
10:30-11:00 (30min)
› MRI guided radiotherapy: the effect of a strong magnetic field in alanine dosimetry - Ilias Billas, National Physical Laboratory, Teddington, Middlesex, TW11 0LW, UK
11:00-11:30 (30min)
